The extended-release GLP-1 agonist was added to usual care in T2DM patients with and without previous cardiac disease.
Are you a US-based MD who sees patients with diabetes and likes to write? Why not blog for EndocrinologyNetwork.com? Be heard on topics that keep you up at night. Contact us here and we can send you the details.